Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
4
×
biotech
boston blog main
deals
4
×
life sciences
national blog main
national top stories
boston top stories
clinical trials
fda
hepatitis b
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
rna interference
san francisco blog main
sanofi
startups
vir biotechnology
abbvie
akouos
alexion pharmaceuticals
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
beijing
biogen
bluerock therapeutics
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
brii bio
brii biosciences
What
medicines
4
×
drug
deal
disease
hepatitis
new
acquire
acquisitions
adds
agreed
alliance
announced
areas
billion
bio
biosciences
bio’s
brii
brings
cash
caught
causing
ceo
cholesterol
collabs
company
compound
covid
daniel
dicerna
earlier
eye
fda
gene
gilead
gilead’s
help
infectious
intended
introduce
Language
unset
Current search:
medicines
×
deals
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline